Human leukocyte antigen-C in short- and long- term liver graft acceptance

Liver Transplantation

Volumn 9, Issue 3, 2003, Pages 218-227

  Moya Quiles, Maria Rosa ^a   Muro, Manuel ^a   Torío, Alberto ^a   Sánchez Bueno, Francisco ^a   Miras, Manuel ^a   Marían, Luis ^a   García Alonso, Ana Maria ^a   Parrilla, Pascual ^a   Dausset, Jean ^b   Álvarez López, María Rocío ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b Ctr d'Etude du Polymorphisme Hum   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; AZATHIOPRINE; CYCLOSPORIN A; HLA C ANTIGEN; METHYLPREDNISOLONE;

ADULT; AGED; ALLOIMMUNITY; ARTICLE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037340587     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50043     Document Type: Article

References (49)

1. Opelz G, Wujciak T, Döhler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Rev Immunogenet 1999; 1:334-342.
2. Takemoto S, Terasaki PI, Cecka JM, Cho YW, Cjerston DW. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N England J Med 1992;327:834-839.
3. Morris PJ. HLA matching and cardiac transplantation. N Engl J Med 1994;330:857-858.
4. Neuberger JM, Adams DH. Is HLA matching important for liver transplantation? J Hepatol 1990;11:1-4.
5. Nikaein A, Backman L, Jennings L, Levy ME, Goldstein R, Gonwa T, Stone MJ, et al. HLA compatibility and liver transplant outcome. Transplantation 1994;58:786-792.
6. Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli-Vergani G, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998;66:53-58.
7. Adams D. Studies of human liver allograft rejection. Semin Liver Dis 1992;12:80-88.
8. Fung JJ, Zeevi A, Starlz TE, Demetris AJ, Iwatsuki S, Duquesnoy RJ. Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986; 16:182-199.
9. Minguela A, Torío A, Marín L, Muro M, Villar LM, Díaz J, et al. Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance. Hum Immunol 1999;60:500-509.
10. Muro M, Álvarez-López MR, Torío A, Ontañon J, Minguela A, Marín L, et al. HLA-DRB1 and -DQB1 polymorphism in liver recipients: Relationship between HLA-DQB1*0302 allele frequency and acute rejection. Hum Immunol 1997;56:70-76.
11. Donaldson PT, Alexander GJ, O'Grady J, Neuberger J, Portmann B, Thick M, et al. Evidence for an immune response to HLA class I antigens in the vanishingbileduct syndrome after liver transplantation. Lancet 1987;1:945-951.
12. Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome: Does HLA exert a dualistic effect? Transplantation 1988; 46:372-377.
13. Donaldson P, Underhill J, Doherty D, Hayllark K, Calne R, Tan KC, er al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: The dualistic effect. Hepatology 1993;17:1008-1015.
14. Ontañon J, Muro M, García-Alonso AM, Minguela A, Torío A, Bermejo J, et al. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Transplantation 1998;65:1047-1053.
15. Littaua RA, Oldstone MB, Takeda A, Debouck C, Wong JT, Tuazon CU, et al. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognises a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol 1991;65: 4051-4056.
16. Johnson RP, Trocha A, Buchanan TM, Walker BD. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp 120 by an HIA-Cw4-restricted cytotoxic T-lymphocyte clone. J Virol 1993;67:438-445.
17. Roitberg-Tambur A, Friedman A, Tzofoni EE, Ashina A, Brautbar C. Do specific pockets of HLA-C molecules predispose to psoriasis vulgaris? J Am Acad Dermatol 1994;31:964-968.
18. Grunnet N, Kristensen T, Kissmeyer-Nielsen F. Cell mediated lympholysis in man: the impact of HLA-C antigens. Tissue Antigens 1976;7:301-309.
19. Chapman JR, Taylo CJ, Ting A, Morris PJ. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986;42:91-93.
20. Baan CC, Vaessen LM, ten Kate F, Schreuder GM, Claas FH, Weimar W, et al. Rejection of a kidney mismatched only for the HLA-C locus and an HLA-Bw22 split. Transplantation 1992; 55:438-439.
21. Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Exp Hematol 1995;23:1667-1675.
22. Lanier LL, Gumperz JE, Parham P, Melero I, López-Botet M, Phillips JH. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995; 154:3320-3327.
23. Mandelboim BO, Reyburn HT, Váles-Gómez M, Pazmany L, Colonna M, Borsellino G, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocopatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med 1996;184:913-922.
24. Falk CS, Schendel DJ. HLA-C revisited. Immunol Res 1997;16: 203-214.
25. Ludwig J. Terminology of hepatic allograft rejection (glossary). Semin Liver Dis 1992;12:89-92.
26. Mor E, Solomon H, Gibbs JF, Holman MJ, Goldstein RM, Husberg BS, et al. Acute cellular rejection following liver transplantation: Clinical pathologic features and effect on outcome. Semin Liver Dis 1992;12:28-40.
27. Ayres R, Adams D. Acute rejection of human liver allografts. In: Neuberger J, Adams D, eds. Immunology of Liver Transplantation. Boston, MA: Edward Arnold, Hodder, & Stoughton; 1993, 197.
28. Marsh SG, Bodmer JG, Albert ED, Bodmer WE, Bontrop RE, Dupont B, et al. Nomenclature for factors of the HLA system, 2000. Tissue Antigens 2001;57:236-283.
29. Svejgaard A, Ryder LP. HLA and disease associations: Detecting the strongest association. Tissue Antigens 1994;43:18-27.
30. Armitage P, Berry G. Estadística Para la Investigación Biomédica. Madrid, Spain: Harcourt Brace; 1997, 112.
31. Bunce M, Welsh KI. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): Identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 1994;43:7-17.
32. Donaldson PT, Williams R. Cross-matching in liver transplantation. Transplantation 1997;63:789-794.
33. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation-friend or foe? Immunity 2001;14:357-368.
34. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: Implications for the expression of HLA-C. J Exp Med 1992;176:937-950.
35. Falk K, Rötzschke O, Grahovac B, Schendel D, Stevanovic S, Gnau V, et al. Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA 1993;90:12005-12009.
36. Gonzalez S, Martinez-Borra J, Sanchez del Rio J, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, et al. The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol 2000;115: 824-828.
37. Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995;59:919-921.
38. Muro M, Marín L, Torío A, Moya-Quiles MR, Ontañon J, Minguela A, et al. Effect of HLA matching on liver graft survival. Transplant Proc 1999;31:2477-2479.
39. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of rwo human donors. Immunity 1997;7:739-751.
40. Young NT, Bunce M, Morris PJ, Welsh KI. Killer cell inhibitory receptor interactions with HLA class I molecules. Implications for alloreactivity and transplantation. Hum Immunol 1997;52:1-12.
41. Leibson PJ. Signal transduction during natural killer cell activation: Inside the mind of a killer. Immunity 1997;6:655-661.
42. Oertel M, Kohlhaw K, Diepolder HM, Schroder S, Schwarz R, Tannapfel A, et al. Alloreactivity of natural killer cells in allogeneic liver transplantation. Transplantation 2001;72:116-122.
43. Hall BM. Cells mediating allograft rejection. Transplantation 1991;51:1141-1151.
44. Poindexter NJ, Steward NS, Shenoy S, Jendrisak MD, Flye MW, Howard TK, et al. Cytolytic T lymphocytes from human renal allograft biopsies are tissue specific. Hum Immunol 1995; 44:43-49.
45. Lipman ML, Stevens AC, Strom TB. Heightened intragraft CTL gene expression in acutely rejection renal allografts. J Immunol 1994;152:5120-5127.
46. Murphy WJ, Reynolds CW, Tiberghien P, Longo DL. Natural killer cells and bone marrow transplantation. J Natl Cancer Inst 1993;85:1475-1482.
47. Minguela A, Bermejo J, Pons JA, Miras M, Torío A, Marín L, et al. HLA class I expression on peripheral blood lymphocytes and hepatocytes after liver transplantation. Transplant Proc 1999;31: 2466-2468.
48. Lefebvre S, Moureau P, Dausset J, Carosella ED, Paul P. Down-regulation of HLA gene transcription in chorionic carcinoma cells is controled for proximal promoter element and can be reversed by CIITA. Placenta 1999;20:293-301.
49. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000;21:376-387. f